lysophosphatidic acid has been researched along with Dyslipidemia in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Parolini, C | 1 |
| Anantharamaiah, GM; Buga, GM; Chattopadhyay, A; Danciger, JS; Farias-Eisner, R; Fogelman, AM; Gao, F; Grijalva, V; Hough, G; Lusis, AJ; Meriwether, D; Navab, M; Org, E; Pan, C; Reddy, ST; Smyth, SS; Su, F; Van Lenten, BJ; Wagner, AC | 1 |
| Remaley, AT | 1 |
| Bea, AM; Calmarza, P; Cenarro, A; Civeira, F; Ferrando, J; Jarauta, E; Mateo-Gallego, R; Puzo, J | 1 |
| Anantharamaiah, GM; Chattopadhyay, A; Faull, KF; Fogelman, AM; Fogelman, SI; Grijalva, V; Hough, G; Hwang, LH; Meriwether, D; Navab, M; Reddy, ST; Su, F; Wagner, AC | 1 |
| Desai, P; Gahtan, V; Maier, KG; Siddiqui, SA; Stein, JJ | 1 |
1 review(s) available for lysophosphatidic acid and Dyslipidemia
| Article | Year |
|---|---|
Biotechnology Approaches for the Treatment of Dyslipidemia.
Topics: Antibodies, Monoclonal, Humanized; Apolipoproteins B; Cholesterol, LDL; Clinical Trials as Topic; Dyslipidemias; Genetic Therapy; Humans; Hypolipidemic Agents; Lysophospholipids; Oligonucleotides, Antisense; RNA, Small Interfering; Triglycerides | 2021 |
1 trial(s) available for lysophosphatidic acid and Dyslipidemia
| Article | Year |
|---|---|
Effect of Nicotinic acid/Laropiprant in the lipoprotein(a) concentration with regard to baseline lipoprotein(a) concentration and LPA genotype.
Topics: Apolipoproteins B; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Dyslipidemias; Female; Genotype; Humans; Indoles; Lipoprotein(a); Lysophospholipids; Male; Middle Aged; Niacin; Polymorphism, Genetic; Triglycerides | 2014 |
4 other study(ies) available for lysophosphatidic acid and Dyslipidemia
| Article | Year |
|---|---|
Transgenic 6F tomatoes act on the small intestine to prevent systemic inflammation and dyslipidemia caused by Western diet and intestinally derived lysophosphatidic acid.
Topics: Animals; Apolipoprotein A-I; Diet; Dyslipidemias; Female; Gene Expression Regulation; Inflammation; Intestine, Small; Lysophospholipids; Mice; Peptidomimetics; Plants, Genetically Modified; Receptors, LDL; Solanum lycopersicum; Western World | 2013 |
Tomatoes, lysophosphatidic acid, and the small intestine: new pieces in the puzzle of apolipoprotein mimetic peptides?
Topics: Animals; Diet; Dyslipidemias; Female; Intestine, Small; Lysophospholipids; Peptidomimetics; Solanum lycopersicum | 2013 |
Source and role of intestinally derived lysophosphatidic acid in dyslipidemia and atherosclerosis.
Topics: Animals; Aorta; Atherosclerosis; Benzoxazoles; Dietary Fats; Dyslipidemias; Female; Group IB Phospholipases A2; Intestinal Absorption; Intestinal Mucosa; Intestines; Jejunum; Liver; Lysophosphatidylcholines; Lysophospholipids; Male; Mice; Phosphoric Diester Hydrolases; Piperazines; Receptors, LDL | 2015 |
Dyslipidemia regulates thrombospondin-1-induced vascular smooth muscle cell chemotaxis.
Topics: Cells, Cultured; Chemotaxis; Dyslipidemias; Humans; Lipoproteins, HDL; Lipoproteins, LDL; Lysophospholipids; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Receptors, Lysophosphatidic Acid; Receptors, Lysosphingolipid; RNA Interference; Signal Transduction; Sphingosine; Sphingosine-1-Phosphate Receptors; Thrombospondin 1; Time Factors; Transfection | 2015 |